Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
After finishing at $1.16 in the prior trading day, Gossamer Bio Inc (NASDAQ: GOSS) closed at $1.13, down -2.59%. In other words, the price has decreased by -$2.59 from its previous closing price. On the day, 1.0 million shares were traded.
Ratios:
Our goal is to gain a better understanding of GOSS by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.71 and its Current Ratio is at 5.71.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on June 25, 2024, initiated with a Outperform rating and assigned the stock a target price of $9.
UBS Downgraded its Buy to Neutral on July 27, 2023, whereas the target price for the stock was revised from $8 to $1.25.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 24 ’24 when Aranda Richard sold 1,908 shares for $0.66 per share. The transaction valued at 1,260 led to the insider holds 196,891 shares of the business.
Hasnain Faheem bought 372,000 shares of GOSS for $250,282 on Jun 21 ’24. The President & CEO now owns 5,408,073 shares after completing the transaction at $0.67 per share. On Jun 18 ’24, another insider, Giraudo Bryan, who serves as the COO/CFO of the company, bought 100,000 shares for $0.59 each. As a result, the insider paid 59,110 and bolstered with 480,010 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 2.06.
Stock Price History:
Over the past 52 weeks, GOSS has reached a high of $1.55, while it has fallen to a 52-week low of $0.50. The 50-Day Moving Average of the stock is 8.60%, while the 200-Day Moving Average is calculated to be 14.79%.
Shares Statistics:
A total of 227.22M shares are outstanding, with a floating share count of 182.66M. Insiders hold about 19.64% of the company’s shares, while institutions hold 58.36% stake in the company.
Earnings Estimates
The stock of Gossamer Bio Inc (GOSS) is currently drawing attention from 7.0 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is -$0.18, with high estimates of -$0.15 and low estimates of -$0.21.
Analysts are recommending an EPS of between -$0.61 and -$0.8 for the fiscal current year, implying an average EPS of -$0.69. EPS for the following year is -$0.47, with 7.0 analysts recommending between -$0.11 and -$0.81.
Revenue Estimates
A total of 9 analysts have provided revenue estimates for GOSS’s current fiscal year. The highest revenue estimate was $59.8M, while the lowest revenue estimate was $9.89M, resulting in an average revenue estimate of $26.71M. In the same quarter a year ago, actual revenue was $114.7M
